MicroRNAs mediate the anti-tumor and protective effects of ginsenosides. (16th November 2020)

• Record Type: Journal Article
• Authors: Ashrafizadeh, Milad; Ahmadi, Zahra; Mohammadinejad, Reza; Farkhondeh, Tahereh; Samarghandian, Saeed
• Is Part Of: Nutrition and cancer. Volume 72:Number 8(2020)
• Page Start: 1264
• Page End: 1275
• Publication Date: 2020-11-16
• Subjects: Cancer -- Periodicals; Nutrition -- Periodicals; Cancer; Nutrition; Periodicals; 616.9940654
• DOI: 10.1080/01635581.2019.1675722
• Languages: English
• ISSNs: 0163-5581

Abstract

Abstract: MicroRNAs (miRs(, as short non-coding RNAs, regulate important biological processes and mainly are associated with regulation of gene expression. The miRs are beneficial targets for diagnosis of various disorders, particularly cancer, since their expression profile undergoes alterations in pathological conditions. The numerous drugs have been designed with the capability of targeting miRs for treating pathological conditions. On the other hand, the application of naturally occurring compounds has been increased due to their minimal side effects and valuable biological and therapeutic activities. Ginsenosides are able to act as anti-tumor agents via either increasing or decreasing the expression level of miRs. Ginsenosides affect the expression profile of miRNAs to induce their protective impacts. Angiogenesis as a key factor in the progression of cancer can be suppressed by ginsenosides which is mediated by miR regulation. The aim of this review is to shed some light on the protective and anti-tumor activities of ginsenosides mediated by miRNAs.